THE WHAT? BeautyHealth has announced that CEO Andrew Stanleick has resigned from his role as President and CEO and will relinquish his seat on the Board, effective November 19, 2023. Beauty Health Director, Maria Beck will serve as Interim CEO while a formal search is conducted by the Board.
THE DETAILS No reason was given for his departure but it coincided with the announcement of the company’s third-quarter results, which detailed lower-than-expected US revenue and US$63,1 million in restructuring charges related to device upgrades of early generation Syndeo devices. Stanleick will continue to serve in an advisory role with the company through the end of the year.
THE WHY? Board Chairman Brent Saunders, explains, “Marla is a beauty industry veteran and trusted voice on the BeautyHealth Board. Her deep entrepreneurial leadership experience and connection to the category will serve as a steadying force with the team, while the Board completes its search for a new CEO. The Board maintains confidence in BeautyHealth’s strategy and long-term growth prospects.”